BackConduit Pharmaceuticals- Warrants (22/09/2028) Overview

Conduit Pharmaceuticals- Warrants (22/09/2028) Inventory

Conduit Pharmaceuticals- Warrants (22/09/2028)'s inventory is $420M.

Get informed when a big investor buys or sells

+ Follow
Inventory
$420.59M
↑ 8.18% YoYΔ $31.80M vs prior year quarter

Peer trimmed avg / median

Loading

Conduit Pharmaceuticals- Warrants (22/09/2028) Inventory History

Loading

Conduit Pharmaceuticals- Warrants (22/09/2028) vs. peers: Inventory Comparison

Loading

Conduit Pharmaceuticals- Warrants (22/09/2028) Inventory Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Conduit Pharmaceuticals- Warrants (22/09/2028) (CDTTW) FAQ

As of the most recent data (June 2026), CDTTW shows a inventory of $420M. That compares with $390M in the prior-year period — up 8.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CDTTW's inventory is now $420M (was $390M) — a 8.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Conduit Pharmaceuticals- Warrants (22/09/2028) is outperforming or lagging.

Tracking CDTTW's inventory over time shows whether Conduit Pharmaceuticals- Warrants (22/09/2028) is scaling, shrinking, or reshaping that part of the business. The current reading is $420M That compares with $390M in the prior-year period — up 8.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Conduit Pharmaceuticals- Warrants (22/09/2028)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $420M) with ownership activity and broader fundamentals.